HAEGARDA Trademark

Trademark Overview

On Wednesday, January 6, 2016, a trademark application was filed for HAEGARDA with the United States Patent and Trademark Office. The USPTO has given the HAEGARDA trademark a serial number of 86867299. The federal status of this trademark filing is SECTION 8 - ACCEPTED as of Friday, August 26, 2022. This trademark is owned by CSL Behring GmbH. The HAEGARDA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, C1 inactivator for the treatment of hereditary angioedema
haegarda

General Information

Serial Number86867299
Word MarkHAEGARDA
Filing DateWednesday, January 6, 2016
Status701 - SECTION 8 - ACCEPTED
Status DateFriday, August 26, 2022
Registration Number5158875
Registration DateTuesday, March 14, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 12, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, C1 inactivator for the treatment of hereditary angioedema

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 14, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCSL Behring GmbH
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMarburg 35041
DE
Party NameCSL Behring GmbH
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMarburg 35041
DE
Party NameCSL Behring GmbH
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMarburg 35041
DE

Trademark Events

Event DateEvent Description
Friday, August 26, 2022NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Friday, August 26, 2022REGISTERED - SEC. 8 (6-YR) ACCEPTED
Friday, August 26, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, March 21, 2022TEAS SECTION 8 RECEIVED
Monday, March 14, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, December 18, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, December 18, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 14, 2017REGISTERED-PRINCIPAL REGISTER
Wednesday, February 8, 20171(B) BASIS DELETED; PROCEED TO REGISTRATION
Wednesday, February 1, 2017NOTICE OF ALLOWANCE CANCELLED
Wednesday, February 8, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, February 1, 2017TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, November 1, 2016ASSIGNED TO EXAMINER
Tuesday, September 6, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 12, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 12, 2016PUBLISHED FOR OPPOSITION
Wednesday, July 6, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 6, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, June 22, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 7, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, May 31, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, May 13, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 13, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 12, 2016ASSIGNED TO LIE
Thursday, April 28, 2016TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, April 22, 2016NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, April 22, 2016LETTER OF SUSPENSION E-MAILED
Friday, April 22, 2016SUSPENSION LETTER WRITTEN
Thursday, April 21, 2016ASSIGNED TO EXAMINER
Thursday, January 14, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Wednesday, January 13, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 13, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, January 9, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

haegarda hereditary angioedema treatment inactivator preparations namely pharmaceutical